Back

Coupling proximity biotinylation with genomic targeting to characterize locus-specific changes in chromatin environments

Kougnassoukou Tchara, P.-E.; Loehr, J.; Lambert, J.-P.

2024-07-26 biochemistry
10.1101/2024.07.26.605321 bioRxiv
Show abstract

Regulating gene expression involves significant and frequent changes in the chromatin environment at the locus level, especially at regulatory sequences. However, their modulation in response to pharmacological treatments or pathological conditions remain mostly undetermined. Here, we report versatile locus-specific proteomics tools to address this knowledge gap, which combine the targeting ability of the CRISPR/Cas9 system and the protein-labelling capability of the highly reactive biotin ligases TurboID (in CasTurbo) and UltraID (in CasUltra). CasTurbo and CasUltra enabled rapid chromatin protein labelling under mild conditions at repetitive sequences like centromeres and telomeres, as well as non-amplified genes. We applied CasUltra to A375 melanoma cell lines to decipher the protein environment of the MYC promoter and characterize the molecular effects of the bromodomain inhibitor JQ1, which targets bromodomain and extra-terminal (BET) proteins that regulate MYC expression. We quantified the consequences of BET protein displacement from the MYC promoter and found that it was associated with a considerable reorganisation of the chromatin composition. In addition, BET protein retention at the MYC promoter was consistent with a model of increased JQ1 resistance. Thus, through the combination of proximity biotinylation and CRISPR-Cas9-dependent genomic targeting, CasTurbo and CasUltra have successfully demonstrated their utility in profiling the proteome associated with a genomic locus in living cells. In BriefKougnassoukou Tchara et al. report the development and application of CasTurbo and CasUltra, two locus-specific proteomics tools that fuse catalytically dead Cas9 to the engineered biotin ligases TurboID and UltraID. These tools enabled the quantitative mapping of locus-specific chromatin remodelling due to pharmacological inhibition. HighlightsO_LICasTurbo and CasUltra were developed for locus-specific label-free proteomics C_LIO_LICasTurbo mapped the proteins localized to the centromeres and telomeres C_LIO_LIProteins bound to the MYC promoter were quantified in melanoma cells with CasUltra C_LIO_LICasUltra is compatible with investigating pharmacological treatment effects C_LI Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=191 SRC="FIGDIR/small/605321v1_ufig1.gif" ALT="Figure 1"> View larger version (50K): org.highwire.dtl.DTLVardef@1f05800org.highwire.dtl.DTLVardef@21754dorg.highwire.dtl.DTLVardef@9c4cc4org.highwire.dtl.DTLVardef@17412a4_HPS_FORMAT_FIGEXP M_FIG C_FIG

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.